Epstein Barr Virus

Epstein-Barr virus, frequently referred to as EBV, is a member of the herpesvirus family and one of the most common human viruses. The virus occurs worldwide, and most people become infected with EBV sometime during their lives.

Multiple Sclerosis and the Epstein Barr Virus

Epstein-Barr virus (EBV) is a herpes virus otherwise known of as human herpesvirus 4 (HHV-4). It is most well known for causing glandular fever but research shows that EBV infection is also linked to an increased risk for various autoimmune conditions including rheumatoid arthritis, dermatomyositis and multiple sclerosis.

What is the Epstein-Barr Virus?

EU funds the international "BEHIND-MS" consortium to tackle multiple sclerosis

Multiple sclerosis (MS), an inflammatory disease of the central nervous system, affects more than 1 million people in Europe and an estimated 2.8 million worldwide.

7 Dec 2023

Genetic mutation in OXR1 gene linked to brain development issues

Study investigates the effects of a loss-of-function mutation in the OXR1 gene on neurodevelopment and cellular functions in the human brain. The research shows that OXR1 deficiency impairs neural differentiation, increases sensitivity to oxidative stress, and alters histone methylation, impacting brain development and potentially contributing to neurological disorders.

27 Nov 2023

Study uncovers interplay of lifestyle choices and DNA methylation in gastric neoplasia risk

A new paper in The Lancet eBioMedicine explores whether these changes predict the future risk of stomach tumors and how epigenetic changes interact with environmental and lifestyle factors in this process.

30 Oct 2023

Long COVID's biological blueprint: new study offers promising insights

Researchers designed a cross-sectional study to investigate the biological underpinnings of “Long COVID”, the post-acute infection syndrome triggered by SARS-CoV-2.

27 Sep 2023

Long COVID patients exhibit different immune and hormonal responses to the virus, study shows

People who have experienced brain fog, confusion, pain, and extreme fatigue for months or longer after being infected with the COVID-19 virus exhibit different immune and hormonal responses to the virus than those not diagnosed with long COVID, according to a new study by researchers at Yale School of Medicine and Icahn School of Medicine at Mount Sinai.

25 Sep 2023

Unveiling the role of EBV in the onset and progression of multiple sclerosis

Recent evidence strongly implicates infection by the Epstein-Barr virus (EBV) as the trigger for development of multiple sclerosis (MS). An international research team is now gathering to unveil the role of EBV in the onset and progression of the MS disease.

20 Sep 2023

Scientists find way to 'press self-destruct button' in gastric cancer associated with Epstein-Barr Virus

Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the journal mBio.

22 Aug 2023

Moffitt receives NCI grant to investigate virus-associated tumors among HIV patients in sub-Saharan Africa

The Center for Immunization and Infection Research in Cancer at Moffitt Cancer Center is expanding its viral infection research in Africa. The cancer center has received a $5.5 million, five-year specialized research center grant (U54CA277834) from the National Cancer Institute to investigate virus-associated tumors that disproportionately impact men and women living with HIV in sub-Saharan Africa.

17 Aug 2023

Teeth may be able to preserve antibodies for hundreds of years, study reveals

Teeth could be capable of preserving antibodies for hundreds of years, allowing scientists to investigate the history of infectious human diseases, a new study has found.

16 Aug 2023

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

Scientists have developed a lymph node-targeted multi-epitope subunit vaccine that induces strong humoral and cellular immune responses against EBV in mice.

14 Aug 2023

Exploring DNA methylation biomarkers of multiple sclerosis

Researchers identify cell-specific DNA methylation signatures associated with MS.

14 Aug 2023

Researchers uncover genetic machinery responsible for EBV-induced B cell growth transformation

B cells or B lymphocytes are an important part of the body's immune system. When healthy B cells are infected with the Epstein-Barr virus (EBV), they undergo growth transformation, a process that immortalizes B cells, leading to their uncontrolled proliferation.

7 Aug 2023

Study sheds light on mechanisms behind a rare disease found almost exclusively in boys

A University of Ottawa-led research team has published rigorous new research that advances a quest to understand a puzzling – and heartbreaking – ultra-rare disease that's found almost exclusively in boys.

3 Aug 2023

New targets for psoriasis treatment? Study reveals 165 associated genes

Researchers conducted a transcriptome-wide association study.

25 Jul 2023

Unveiling long COVID: new study explores symptoms and strain variations

Researchers investigated the variation in the clinical and demographic characteristics of acute SARS-CoV-2.

17 Jul 2023

2023 recipients of the Diversity in Lupus Research Awards announced

The Lupus Research Alliance is pleased to announce the 2023 recipients of the Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research.

12 Jul 2023

Space travel weakens immune system by altering gene expression in white blood cells

Evidence is mounting that astronauts are more susceptible to infections while in space. For example, astronauts on board the International Space Station (ISS) commonly suffer from skin rashes, as well as respiratory and non-respiratory diseases.

24 Jun 2023

The immunopathology of post-acute sequelae of SARS-CoV-2 infection: highlighting the knowledge gaps

The immunopathology of post-acute sequelae of SARS-CoV-2 infection (PASC).

31 May 2023

Novel treatment targets against natural killer/T-cell lymphoma identified

A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has discovered that a transcription factor, TOX2, was aberrantly increased in patients with Natural killer/T-cell lymphoma (NKTL).

29 May 2023

Exercise capacity found to be lower than expected among people with long COVID

While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.

25 May 2023

Epstein Barr Virus

Overview

What is the Epstein-Barr Virus?

Latest Epstein Barr Virus News and Research

EU funds the international "BEHIND-MS" consortium to tackle multiple sclerosis

Genetic mutation in OXR1 gene linked to brain development issues

Study uncovers interplay of lifestyle choices and DNA methylation in gastric neoplasia risk

Long COVID's biological blueprint: new study offers promising insights

Long COVID patients exhibit different immune and hormonal responses to the virus, study shows

Unveiling the role of EBV in the onset and progression of multiple sclerosis

Scientists find way to 'press self-destruct button' in gastric cancer associated with Epstein-Barr Virus

Moffitt receives NCI grant to investigate virus-associated tumors among HIV patients in sub-Saharan Africa

Teeth may be able to preserve antibodies for hundreds of years, study reveals

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

Exploring DNA methylation biomarkers of multiple sclerosis

Researchers uncover genetic machinery responsible for EBV-induced B cell growth transformation

Study sheds light on mechanisms behind a rare disease found almost exclusively in boys

New targets for psoriasis treatment? Study reveals 165 associated genes

Unveiling long COVID: new study explores symptoms and strain variations

2023 recipients of the Diversity in Lupus Research Awards announced

Space travel weakens immune system by altering gene expression in white blood cells

The immunopathology of post-acute sequelae of SARS-CoV-2 infection: highlighting the knowledge gaps

Novel treatment targets against natural killer/T-cell lymphoma identified

Exercise capacity found to be lower than expected among people with long COVID

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Epstein Barr Virus

Overview

Latest Epstein Barr Virus News and Research

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Newsletters you may be interested in